ONE-WAYOngoing theme · still written in the latest filings
Risk of Stagnation in Antibody Therapeutics Market Growth and Competition from Other Modalities
The risk that competition from molecularly targeted drugs, drug delivery systems, regenerative medicine, gene therapy and other modalities will prevent the antibody therapeutics market from expanding as expected, making it difficult to secure business opportunities and revenue.
Companies3How many companies write about this.
Threads3One company can carry more than one thread here.
PeriodFY2017 →Still being written about.
Directionhurts0 helps · 3 hurts · 0 flat